{
    "title": "113_hr5790",
    "content": "The Act titled \"Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014\" introduces prize competitions for improving health outcomes and reducing federal expenditures under the Public Health Service Act. The Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014 aims to improve health outcomes and reduce Federal expenditures on health programs through prize competitions. The Director of NIH, in consultation with relevant parties, will identify 3 to 5 human diseases or health conditions with significant Federal spending for prevention and treatment activities. The Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014 requires the identification of 3 to 5 human diseases or health conditions with significant Federal spending for prevention and treatment activities. The prize competitions aim to address diseases where there is a lack of research investment compared to the level of Federal expenditures. The Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014 mandates the identification of diseases with high Federal spending on prevention and treatment. Prize competitions will be designed by the Director of NIH to encourage innovation in addressing these diseases. The Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014 requires cooperation among competitors to innovate solutions for identified diseases. Prizes will be awarded to the most promising innovations during competitions and to the best solutions at the end. The Act of 2014 mandates competitions for innovative solutions to diseases, with prizes awarded to the best innovations and solutions. Competitions must be realistic, unbiased, and open to all participants. The Act of 2014 mandates unbiased competitions for innovative solutions to diseases, open to all participants regardless of their place of incorporation, primary place of business, citizenship, and residency. The Director of NIH must consult with various experts in medical, economic, budgetary, and innovation fields. The Director of NIH is required to consult with experts and relevant federal agencies to design unbiased competitions for innovative solutions to diseases. Additionally, the Director must award contracts for a simulation of the prize within 14 months of the enactment of the Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014. The Director of NIH must award contracts for a simulation of prize competitions within 14 months of the Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014. The simulation will assess the effectiveness of the design, with a report due to Congress within 4 months of awarding the contracts. The Director of NIH will make adjustments to the design of prize competitions within 21 months of the enactment of the Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014, based on the simulation results. A report on these adjustments will be submitted to Congress. The Director of NIH will adjust prize competition designs based on simulation results and submit a report to Congress. Private entities will implement competitions requiring innovation demonstration over a maximum of 5 years. The Director of NIH will conduct up to 5 prize competitions, with a maximum of 2 per disease or condition, requiring innovation demonstration over a period of not more than 5 years. Qualified competitors may receive guidance and access to testing facilities from the Secretary and the Commissioner of Food and Drugs. The Director of NIH will conduct up to 5 prize competitions, with a maximum of 2 per disease or condition, to track and report on the medical efficacy and impact on Federal expenditures of funded innovations. The Federal Government may not acquire intellectual property rights without consent from participants in prize competitions. They can negotiate licenses for the use of intellectual property developed in these competitions. A report on the innovations' impact on Federal expenditures must be submitted to Congress annually for five years after the competitions. Authorization of Appropriations: $50,000,000 is authorized to be appropriated for carrying out this section. Not more than 30 percent of total assistance awarded to private entities for prize competitions can be used. Under this section, a minimum percentage of assistance awarded to private entities for prize competitions must be allocated for prizes to competitors, with not more than 30 percent for administration. Additionally, certain prizes for improving health outcomes are excluded from gross income of recipients according to an amendment to the Internal Revenue Code of 1986. Certain prizes for improving health outcomes are excluded from gross income of recipients under an amendment to the Internal Revenue Code of 1986. This amendment applies to taxable years ending after the enactment of the Act."
}